Westwood Holdings Group Inc. Buys 56,802 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Key Points

• Westwood Holdings Group Inc. increased its stake in Prestige Consumer Healthcare by 7.1%, now owning approximately 1.74% of the company, valued at around $74 million.
• Prestige Consumer Healthcare's recent quarterly earnings exceeded expectations, reporting an EPS of $1.32 versus a $1.30 consensus, with annual revenue growth of 7% to $296.52 million.
• Analysts have a consensus rating of "Moderate Buy" for Prestige Consumer Healthcare, with an average target price of $93.33 after several upgrades from major financial institutions.

Westwood Holdings Group Inc. raised its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 7.1% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 861,282 shares of the company's stock after purchasing an additional 56,802 shares during the quarter. Westwood Holdings Group Inc. owned 1.74% of Prestige Consumer Healthcare worth $74,044,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of PBH. Opal Wealth Advisors LLC bought a new stake in Prestige Consumer Healthcare in the 1st quarter worth approximately $38,000. CIBC Private Wealth Group LLC lifted its holdings in Prestige Consumer Healthcare by 48.9% in the fourth quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock valued at $34,000 after acquiring an additional 152 shares during the period. Headlands Technologies LLC bought a new position in Prestige Consumer Healthcare in the fourth quarter valued at about $40,000. McIlrath & Eck LLC grew its stake in shares of Prestige Consumer Healthcare by 19.1% during the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock valued at $75,000 after purchasing an additional 154 shares during the period. Finally, Johnson Financial Group Inc. purchased a new stake in shares of Prestige Consumer Healthcare during the 4th quarter valued at about $93,000. 99.95% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on PBH. Wall Street Zen upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Royal Bank Of Canada upgraded Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $93.33.

Prestige Consumer Healthcare Trading Up 1.4%

Shares of NYSE:PBH traded up $1.05 during trading on Wednesday, reaching $75.09. 451,267 shares of the company were exchanged, compared to its average volume of 424,802. The business's fifty day simple moving average is $80.00 and its 200-day simple moving average is $82.19. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.20 and a quick ratio of 2.82. Prestige Consumer Healthcare Inc. has a 12-month low of $64.94 and a 12-month high of $90.04. The firm has a market capitalization of $3.71 billion, a PE ratio of 17.50, a P/E/G ratio of 2.22 and a beta of 0.43.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.30 by $0.02. The company had revenue of $296.52 million for the quarter, compared to the consensus estimate of $289.36 million. Prestige Consumer Healthcare had a return on equity of 12.87% and a net margin of 18.86%. Prestige Consumer Healthcare's quarterly revenue was up 7.0% on a year-over-year basis. During the same period last year, the business posted $1.02 EPS. On average, research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.